BIOSPECIFICS TECHNOLOGIES CORP — Revenue by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c40227c6-3004-406f-9f26-1a80d8a28475/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2019 | $38.2M | 2019-01-01 – 2019-12-31 | evidence 0001140361-20-005848 |
| FY 2018 | $33.0M | 2018-01-01 – 2018-12-31 | evidence 0001140361-19-006323 |
| FY 2017 | $27.4M | 2017-01-01 – 2017-12-31 | evidence 0001140361-19-006323 |
| FY 2016 | $26.3M | 2016-01-01 – 2016-12-31 | evidence 0001140361-19-006323 |
| FY 2015 | $22.8M | 2015-01-01 – 2015-12-31 | evidence 0001140361-16-057622 |
| FY 2014 | $14.0M | 2014-01-01 – 2014-12-31 | evidence 0001140361-16-057622 |
| FY 2013 | $14.4M | 2013-01-01 – 2013-12-31 | evidence 0001140361-16-057622 |
| FY 2012 | $11.1M | 2012-01-01 – 2012-12-31 | evidence 0001140361-13-012763 |
| FY 2011 | $11.4M | 2011-01-01 – 2011-12-31 | evidence 0001140361-12-015150 |
| FY 2010 | $5.7M | 2010-01-01 – 2010-12-31 | evidence 0001140361-12-015150 |
| FY 2009 | $3.2M | 2009-01-01 – 2009-12-31 | evidence 0001140361-12-015150 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
BIOSPECIFICS TECHNOLOGIES CORP — all facts · Net Income · Operating Income